chromatography in drug metabolism: validation and applications. J Chromatogr A
2006;1133:184–194.
Bu HZ, Kang P, Zhao P, Pool WF, Wu EY. A simple sequential incubation method for
deconvoluting the complicated sequential metabolism of capravirine in humans.
Drug Metab Dispos 2005;33:1438–1445.
Buchholz BA, Fultz E, Haack KW, Vogel JS, Gilman SD, Gee SJ, Hammock BD, Hui
X, Wester RC, Maibach HI. HPLC–accelerator MS measurement of atrazine
metabolites in human urine after dermal exposure. Anal Chem 1999;71:3519–3525.
Chando TJ, Everett DW, Kahle AD, Starrett AM, Vachharajani N, Shyu WC,
Kripalani KJ, Barbhaiya RH. Biotransformation of irbesartan in man. Drug Metab
Dispos 1998;26:408–417.
Dalvie D. Recent advances in the applications of radioisotopes in drug metabolism,
toxicology, and pharmacokinetics. Curr Pharm Des 2000;6:1009–1028.
Dear GJ, Patel N, Kelly PJ, Webber L, Yung M. TopCount coupled to ultra-
performance liquid chromatography for the profiling of radiolabeled drug
metabolites in complex biological samples. J Chromatogr B Analyt Technol
Biomed Life Sci 2006;844:96–103.
Egnash LA, Ramanathan R. Comparison of heterogeneous and homogeneous
radioactivity flow detectors for simultaneous profiling and LC–MS/MS character-
ization of metabolites. J Pharm Biomed Anal 2002;27:271–284.
Ethell BT, Anderson GD, Beaumont K, Rance DJ, Burchell B. A universal
radiochemical high-performance liquid chromatographic assay for the determination
of UDP-glucuronosyltransferase activity. Anal Biochem 1998;255:142–147.
Evans DC, Watt AP, Nicoll-Griffith DA, Baillie TA. Drug-protein adducts: an industry
perspective on minimizing the potential for drug bioactivation in drug discovery and
development. Chem Res Toxicol 2004;17:3–16.
Everett DW, Chando TJ, Didonato GC, Singhvi SM, Pan HY, Weinstein SH.
Biotransformation of pravastatin sodium in humans. Drug Metab Dispos
1991;19:740–748.
Fouda HG, Avery MJ, Dalvie D, Falkner FC, Melvin LS, Ronfeld RA. Disposition and
metabolism of tenidap in the rat. Drug Metab Dispos 1997;25:140–148.
Garner RC. Accelerator mass spectrometry in pharmaceutical research and develop-
ment a new ultrasensitive analytical method for isotope measurement. Curr Drug
Metab 2000;1:205–213.
Garner RC, Goris I, Laenen AA, Vanhoutte E, Meuldermans W, Gregory S, Garner
JV, Leong D, Whattam M, Calam A, Snel CA. Evaluation of accelerator mass
spectrometry in a human mass balance and pharmacokinetic study-experience with
14C-labeled (R)-6-[amino(4- chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-
chlorophenyl)-1- methyl-2(1H)-quinolinone (R115777), a farnesyl transferase in-
hibitor. Drug Metab Dispos 2002;30:823–830.
Gedamke R, Zhao W, Gozo S, Mitroka J, Zhu M. A sensitive method for plasma
metabolite identification using nano LC/ion trap MS in conjunction with a
microplate scintillation counter. ASMS Archive Abstract2003.
Graf BA, Mullen W, Caldwell ST, Hartley RC, Duthie GG, Lean ME, Crozier A,
Edwards CA. Disposition and metabolism of [2-14C]quercetin-4^0 -glucoside in rats.
Drug Metab Dispos 2005;33:1036–1043.
314 APPLICATIONS OF LIQUID RADIOCHROMATOGRAPHY TECHNIQUES